Dr. Friedmann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11 Wilbraham Rd
Springfield, MA 01109Phone+1 413-794-3710Fax+1 413-794-9595
Education & Training
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1988 - 1991
- Boston University School of MedicineClass of 1988
Certifications & Licensure
- VT State Medical License 2020 - 2026
- MA State Medical License 1992 - 2025
- NH State Medical License 2020 - 2024
- RI State Medical License 1999 - 2020
- IL State Medical License 1994 - 1999
- NY State Medical License 1989 - 1992
- American Board of Internal Medicine Internal Medicine
- American Board of Preventive Medicine Addiction Medicine
Clinical Trials
- Trazodone for Sleep Disturbance in Early Alcohol Recovery Start of enrollment: 2002 Jun 01
- Step'n Out: A Multisite Trial of Collaborative Behavioral Management for Drug-Involved Parolees Start of enrollment: 2005 Feb 01
- Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site Start of enrollment: 2008 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 91 citationsClinical practice. Alcohol use in adults.Peter D. Friedmann
The New England Journal of Medicine. 2013-01-24 - 34 citationsThe Rural Opioid Initiative Consortium description: providing evidence to Understand the Fourth Wave of the Opioid Crisis.Richard A Jenkins, Bridget M Whitney, Robin M Nance, Todd M Allen, Hannah L F Cooper
Addiction Science & Clinical Practice. 2022-07-26 - 65 citationsA Randomized Trial of Methadone Initiation Prior to Release from IncarcerationMichelle McKenzie, Nickolas Zaller, Samuel Dickman, Traci C. Green, Amisha Parihk
Substance Abuse. 2012-01-01
Press Mentions
- Improving Release Process and Treatment After Incarceration May Reduce Opioid OverdosesAugust 11th, 2022
- Study: Opioid Addiction Treatment in Jail Reduces Re-Arrest Risk After ReleaseJanuary 19th, 2022
- Offering Buprenorphine Medication to People with Opioid Use Disorder in Jail May Reduce Rearrest and ReconvictionJanuary 18th, 2022
- Join now to see all
Grant Support
- Continuum Of Care For Drug-Involved OffendersNational Institute On Drug Abuse2009–2012
- Treatment Study Using Depot Naltrexone(2/6)Rhode Island Protocol Treatment SiteNational Institute On Drug Abuse2008–2012
- Pilot Study Of Depot Naltrexone In Alcohol-Dependent, Homeless VeteransVeterans Affairs2011
- Stabilize Addiction/Affect, Begin Inmates'Interferon For HCV Of Liver (STAABIHL)National Institute On Drug Abuse2007–2009
- Continuity Of Care For Drug-Addicted Offenders In RINational Institute On Drug Abuse2004–2007
- Trazodone For Sleep Disturbance - Early Alcohol RecoveryNational Institute On Alcohol Abuse And Alcoholism2004
- Continuity Of Care For Drug-Addicted Offenders In RINational Institute On Drug Abuse2002–2003
- Trazodone For Sleep Disturbance - Early Alcohol RecoveryNational Institute On Alcohol Abuse And Alcoholism2002–2003
- Linkage To Health Services In Drug Abuse TreatmentNational Institute On Drug Abuse2000–2002
- Trazodone For Sleep Disturbance--Early Alcohol RecoveryNational Institute On Alcohol Abuse And Alcoholism2001
- Linkages To Primary Care In Drug Treatment ProgramsNational Institute On Drug Abuse1998–2000
- Linkages To Primary Care In Drug Treatment ProgramsNational Institute On Drug Abuse1996–1998
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: